La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Mesh.i » - entrée « Dopamine Agonists »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine Agents < Dopamine Agonists < Dopamine Antagonists  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 90.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000011 (1999) J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. MalbezinA randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
000021 (1999) O. Rascol [France]Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?
000024 (1999) N. Vaserman-Lehuédé [France] ; M. VérinShoulder pain in patients with Parkinson's disease.
000033 (1999) O K Hassani [France] ; J. FégerEffects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
000042 (1999) C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. RascolLack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
000047 (????) H. Bagheri [France] ; C. Damase-Michel ; M. Lapeyre-Mestre ; S. Cismondo ; D. O'Connell ; J M Senard ; O. Rascol ; J L MontastrucA study of salivary secretion in Parkinson's disease.
000064 (1999) J L Montastruc [France] ; O. Rascol ; J M SenardTreatment of Parkinson's disease should begin with a dopamine agonist.
000072 (1999) C. Fillebeen [France] ; V. Mitchell ; D. Dexter ; M. Benaissa ; J. Beauvillain ; G. Spik ; A. PierceLactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment.
000125 (2000) R. Bordet [France] ; S. Ridray ; J C Schwartz ; P. SokoloffInvolvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
000127 (2000) O. Rascol [France] ; J L Montastruc[Role of dopaminergic agonists].
000163 (2001) O. Rascol [France] ; J G Nutt ; O. Blin ; C G Goetz ; J M Trugman ; C. Soubrouillard ; J H Carter ; L J Currie ; N. Fabre ; C. Thalamas ; W W Giardina ; S. WrightInduction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
000199 (2000) Pergolide and Parkinson's disease: new preparation. No clear benefit.
000208 (2001) O. Rascol [France] ; J J Ferreira ; C. Thalamas ; M. Galitsky ; J L MontastrucDopamine agonists. Their role in the management of Parkinson's disease.
000222 (2001) S. Thobois [France] ; S. Guillouet ; E. BroussolleContributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
000245 (2001) J. Xie [France] ; P. Krack ; A L Benabid ; P. PollakEffect of bilateral subthalamic nucleus stimulation on parkinsonian gait.
000259 (2002) André Nieoullon [France]Dopamine and the regulation of cognition and attention.
000271 (2002) C. Lebrun-Frenay [France] ; M. BorgChoosing the right dopamine agonist for patients with Parkinson's disease.
000315 (2003) G. Fénelon [France] ; S. Giménez-Roldán ; J L Montastruc ; F. Bermejo ; F. Durif ; I. Bourdeix ; J-J Péré ; L. Galiano ; J. SchadrackEfficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
000347 (2003) Olivier Rascol [France]Monoamine oxidase inhibitors--is it time to up the TEMPO?
000392 (2003) Olivier Guillin [France] ; Nathalie Griffon ; Erwan Bezard ; Ludovic Leriche ; Jorge Diaz ; Christian Gross ; Pierre SokoloffBrain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease.
000406 (2003) N V Fedorova[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Dopamine Agonists" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Dopamine Agonists" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dopamine Agonists
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024